Therapeutic doses of glucocorticoids: Implications for oral medicine

Oral Diseases

Volumn 12, Issue 5, 2006, Pages 436-442

  Baid, S K ^a   Nieman, L K ^a,b  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b MSC 1109 ^*  (United States)

Author keywords

Adrenal insufficiency; Glucocorticoids; Hypothalamic pituitary adrenal axis; Inhaled corticosteroids; Steroid supplementation

Indexed keywords

BECLOMETASONE; BUDESONIDE; CICLESONIDE; CORTICOTROPIN; CORTISONE ACETATE; DEXAMETHASONE; FLUDROCORTISONE; FLUNISOLIDE; FLUTICASONE PROPIONATE; GLUCOCORTICOID; HYDROCORTISONE; MOMETASONE FUROATE; PREDNISOLONE; PREDNISONE; TETRACOSACTIDE; TRIAMCINOLONE ACETONIDE;

ADRENAL INSUFFICIENCY; ANXIETY; ASTHMA; ATTENTION; BLOOD CLOTTING DISORDER; BONE DEMINERALIZATION; BONE DENSITY; BRONCHOSPASM; CAPILLARY RESISTANCE; CATARACT; COGNITIVE DEFECT; COUGHING; CUSHING DISEASE; DENTAL CARIES; DEPRESSION; DOSE RESPONSE; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG HALF LIFE; DRUG METABOLISM; DRUG SAFETY; DRUG WITHDRAWAL; DYSPHONIA; FIRST PASS EFFECT; HUMAN; HYPERGLYCEMIA; HYPERTENSION; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IATROGENIC DISEASE; LIBIDO DISORDER; MENORRHAGIA; MOOD CHANGE; MUSCLE WEAKNESS; OBESITY; PERIOPERATIVE PERIOD; PHARYNGITIS; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; PSYCHOSIS; REVIEW; RISK BENEFIT ANALYSIS; SIDE EFFECT; SNEEZING; STRIA; SURGICAL STRESS; THRUSH; WOUND HEALING IMPAIRMENT;

ADMINISTRATION, INHALATION; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUCOCORTICOIDS; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; PERIOPERATIVE CARE; PITUITARY-ADRENAL SYSTEM;

EID: 33747395098     PISSN: 1354523X     EISSN: 16010825     Source Type: Journal    
DOI: 10.1111/j.1601-0825.2006.01290.x     Document Type: Review

References (32)

1. Axelrod L (1976). Glucocorticoid therapy. Medicine (Baltimore) 55: 39-65.
2. Barnes PJ (2006). Corticosteroid effects on cell signaling. Eur Respir J 27: 413-426.
3. Brandon DD, Isabelle LM, Samuels MH, Kendall JW, Loriaux DL (1999). Cortisol production rate measurement by stable isotope dilution using gas chromatography-negative ion chemical ionization mass spectrometry. Steroids 64: 372-378.
4. Brown PH, Blundell G, Greening AP, Crompton GK (1991). Hypothalamo-pituitary-adrenal axis suppression in asthmatics inhaling high dose corticosteroids. Respir Med 85: 501-510.
5. Brown PH, Blundell G, Greening AP, Crompton GK (1992). High dose inhaled steroid therapy and the cortisol excess response to acute severe asthma. Respir Med 86: 495-497.
6. Coursin DB, Wood KE (2002). Corticosteroid supplementation for adrenal insufficiency. JAMA 287: 236-240.
7. Czock D, Keller F, Rasche FM, Haussler U (2005). Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids. Clin Pharmacokinet 44: 61-98.
8. Dahl R (2006). Systemic side effects of inhaled corticosteroids in patients with asthma. Resp Med [ePub Ahead of print]. doi: 10.1016/j.rmed.2005. 11.020.
9. El O, Gulbahar S, Cevlan E et al (2005). Bone mineral density in asthmatic patients using low dose inhaled glucocorticosteroids. J Invest Allergol Clin Immunol 15: 57-62.
10. Ellepola AN, Samaranayake LP (2001). Inhalational and topical steroids, and oral candidosis: a mini review. Oral Dis 7: 211-216.
11. Esteban NV, Loughlin T, Yergey AL et al (1991). Daily cortisol production rate in man determined by stable isotope dilution/mass spectrometry. J Clin Endocrinol Metab 71: 39-45.
12. Feldstein AC, Elmer PJ, Nichols GA, Herson M (2005). Practice patterns in patients at risk for glucocorticoid-induced osteoporosis. Osteoporos Int 16: 2168-2174.
13. Glowniak JV, Loriaux DL (1997). A double-blind study of perioperative steroid requirements in secondary adrenal insufficiency. Surgery 121: 123-129.
14. Gonzalez-Moles MA, Scully C (2005). Vesiculo-erosive oral mucosal disease - management with topical corticosteroids: (2) Protocols, monitoring of effects and adverse reactions, and the future. J Dent Res 84: 302-308.
15. Grinspoon SK (1994). Laboratory assessment of adrenal insufficiency. J Clin Endocrinol Metab 9: 923-931.
16. Gulliver T, Eid N (2005). Effects of glucocorticoids on the hypothalamic-pituitary-adrenal axis in children and adults. Immunol Allergy Clin North Am 25: 541-555.
17. Kehlet H (1975). A rational approach to dosage and preparation of parenteral glucocorticoid substitution therapy during surgical procedures. Acta Anaesth Scand 19: 260-264.
18. Kehlet H, Binder C (1973). Value of an ACTH test in assessing hypothalamic-pituitary-adrenocortical function in glucocorticoid-treated patients. Brit Med J 2: 147-149.
19. Key SJ, Hodder SC, Davies R, Thomas DW, Thompson S (2003). Perioperative corticosteroid supplementation and dento-alveolar surgery. Dent Update 30: 316-320.
20. Komerik N, Akkaya A, Yildiz M, Buyukkaplan US, Kuru L (2005). Oral health in patients on inhaled corticosteroid treatment. Oral Dis 11: 303-308.
21. Krasner AS (1999). Glucocorticoid-induced adrenal insufficiency. JAMA 282: 671-676.
22. Liapi C, Chrousos GP (1992). Glucocorticoids. In: Yaffe SJ, Aranda JV, eds. Pediatric pharmacology, 2nd edn. WB Saunders: Philadelphia, PA, pp. 466-475.
23. Lipworth BJ (1999). Systemic adverse effects of inhaled corticosteroid therapy: a systematic review and meta-analysis. Arch Intern Med 159: 941-955.
24. May ME, Carey RM (1985). Rapid adrenocorticotropic hormone test in practice. Am J Med 79: 679-684.
25. Nieman LK (2003). Dynamic evaluation of adrenal hypofunction. J Endocrinol Invest 26 (Suppl. 7): 74-82.
26. Salem M, Tainsh RE, Jr, Bromberg J, Loriaux DL, Chernow B (1994). Perioperative glucocorticoid coverage. A reassessment 42 years after emergence of a problem. Ann Surg 219: 416-425.
27. Salib RJ, Howarth PH (2003). Safety and tolerability profiles of intranasal antihistamines and intranasal corticosteroids in the treatment of allergic rhinitis. Drug Saf 26: 863-893.
28. Sfzeler S, Rohatagi S, Williams J, Lloyd M, Kundu S, Banerji D (2005). Cicelsonide, a novel inhaled steroid, does not affect HPA axis function in patients with moderate to severe persistent asthma. Chest 128: 1104-1114.
29. Speckart PF, Nicoloff JT, Bethune JE (1971). Screening for adrenocortical insufficiency with cosyntropin (synthetic ACTH). Arch Intern Med 128: 761-763.
30. Todd GR, Acerini CL, Ross-Russell R, Zahra S, Warner JT, McCance D (2002). Survey of adrenal crisis associated with inhaled corticosteroids in the United Kingdom. Arch Dis Child 87: 457-461.
31. Walsh LJ, Wong CA, Oborne J et al (2001). Adverse effects of oral corticosteroids in relation to dose in patients with lung disease. Thorax 56: 279-284.
32. Wogelius P, Poulsen S, Sorensen HT (2004). Use of asthma-drugs and risk of dental caries among 5 to 7 year old Danish children: a cohort study. Community Dent Health 21: 207-211.